Menu Search
Equities

Humana Inc

HUM:NYQ

Humana Inc

Actions
Health CareHealth Care Providers
  • Price (USD)293.73
  • Today's Change0.600 / 0.20%
  • Shares traded440.24k
  • 1 Year change-40.69%
  • Beta0.5293
Data delayed at least 15 minutes, as of Dec 03 2024 17:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 28-Nov-24
Select bar for recommendation details.
Recommendations28-Nov-24
Buy3
Outperform5
Hold18
Sell1
Strong Sell0

Share price forecast in USD

The 22 analysts offering 12 month price targets for Humana Inc have a median target of 285.50, with a high estimate of 374.00 and a low estimate of 248.00. The median estimate represents a -2.60% decrease from the last price of 293.13.
High27.6%374.00
Med-2.6%285.50
Low-15.4%248.00

Dividends in USD

In 2023, Humana Inc reported a dividend of 3.54 USD, which represents a 12.38% increase over last year. The 7 analysts covering the company expect dividends of 3.77 USD for the upcoming fiscal year, an increase of 6.50%.
Div growth (TTM)12.38%
More ▼

Earnings history & estimates in USD

On Oct 30, 2024, Humana Inc reported 3rd quarter 2024 earnings of 4.16 per share. This result exceeded the 3.40 consensus of the 22 analysts covering the company and under-performed last year's 3rd quarter results by 46.53%.
The next earnings announcement is expected on Jan 23, 2025.
Average growth rate-21.98%
Humana Inc reported annual 2023 earnings of 26.09 per share on Jan 25, 2024.
Average growth rate+10.16%
More ▼

Revenue history & estimates in USD

Humana Inc. had 3rd quarter 2024 revenues of 29.30bn. This bettered the 28.67bn consensus of the 17 analysts covering the company. This was 14.22% above the prior year's 3rd quarter results.
Average growth rate+3.67%
Humana Inc. had revenues for the full year 2023 of 102.65bn. This was 10.38% above the prior year's results.
Average growth rate+12.18%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.